Omay, Dallas T.

HRN: 22-76-09  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/16/2023
CEFUROXIME 750MG (VIAL)
12/16/2023
12/22/2023
IV
250mg
Q8
AGE;URTI
Waiting Final Action 
12/18/2023
CLARITHROMYCIN 125MG/5ML, 60ML SUSPENSION (BOT)
12/18/2023
12/25/2023
PO
1.8ml
BID
PCAP C
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: